In patients with FTD, elevated microglial activation has been described in frontotemporal regions across all clinical variants by previous PET studies with TSPO ligands.14–16,18 However, these previous studies did not investigate the association between frontotemporal inflammation and progression. The gene discussed is TSPO; the disease is frontotemporal dementia.